Bio Plus Co

Bio Plus Co FCF per Share

The Free Cash Flow per Share of Bio Plus Co (099430.KQ) as of Nov 20, 2026 is -539.32 KRW. In the previous year, Free Cash Flow per Share was -1,320.68 KRW — a change of -59.16% (higher).

FCF per Share

-539.32KRW

YoY

-59.16%

Last updated:

Free Cash Flow per Share of Bio Plus Co is 2025 -539.32 KRW. Free Cash Flow per Share of Bio Plus Co was 2024 -1,320.68 KRW. It decreases by -59.16% higher compared to the previous year.

The Bio Plus Co FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
43.37 KRW
Jan 1, 2019
-27.88 KRW
Jan 1, 2020
160.80 KRW
Jan 1, 2021
-35.78 KRW
Jan 1, 2022
115.05 KRW
Jan 1, 2023
-96.73 KRW
Jan 1, 2024
-1,320.68 KRW
Jan 1, 2025
-539.32 KRW
The Bio Plus Co FCF per Share history
YEARFCF per ShareYoY
-539.32KRW-59.16%
-1,320.68KRW+1,265.35%
-96.73KRW-184.07%
115.05KRW-421.57%
-35.78KRW-122.25%
160.80KRW-676.84%
-27.88KRW-164.28%
43.37KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio Plus Co Stock analysis

What does Bio Plus Co do? BioPlus Co., Ltd. generates revenue through the manufacturing and sale of dermal fillers, primarily hyaluronic acid fillers for temporary facial wrinkle improvement. The company also produces and sells anti-adhesion agents to prevent surgical adhesions, biomaterials for joint tissue repair, and other tissue restoration products. These products are supplied to medical professionals and healthcare facilities requiring cosmetic and surgical solutions. The firm targets the medical and cosmetic sectors, focusing on tissue restoration applications for both aesthetic and functional needs. The company's product portfolio includes biomaterials for tissue restoration, specifically designed for temporary facial wrinkle correction, anti-adhesion solutions for surgical sites, and joint tissue repair materials. These offerings cater to healthcare providers seeking advanced biomaterials for patient care. BioPlus Co., Ltd. serves the medical industry by providing specialized products that address both cosmetic enhancement and post-surgical recovery requirements. BioPlus Co., Ltd. operates within the biomaterials sector, focusing on dermal fillers and tissue repair solutions. Its products are utilized by medical practitioners for facial aesthetics and surgical applications. The company's revenue streams are derived from direct sales of these biomaterial products to healthcare institutions and professionals in the medical field. Bio Plus Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio Plus Co stock

Free Cash Flow per Share of Bio Plus Co is -539.32 KRW in 2025.

Free Cash Flow per Share of Bio Plus Co changed from -1,320.68 KRW to -539.32 KRW, representing a -59.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Bio Plus Co since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Bio Plus Co

All Key Metrics — Bio Plus Co